FDA Inspection
VKT Pharma Private LimitedVKT Pharma Private Limited – FDA Inspection, Feb 28, 2020
Record Details
This FDA Inspection record concerns VKT Pharma Private Limited, with an inspection on February 28, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- VKT Pharma Private Limited
- Inspection Date
- February 28, 2020
- Product Type
- Drugs
View Company Profile
ID · cdde3285-5d24-4566-8bc1-4f0dfce56e56
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1119188
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.192Written record of investigation incomplete
Full citation text and observation details available on the Dashboard.
Other FDA inspections of VKT Pharma Private Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 7, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
| May 25, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for VKT Pharma Private Limited
- FDA Inspection 1260195 - 2025-02-07
- FDA Inspection 1057019 - 2018-05-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.